CYTORI THERAPEUTICS, INC DEF14A 1-6-2015

Company

PLUS THERAPEUTICS, INC.

Filed

November 24, 2014

Period of Report

January 6, 2015

Accession Number

0001095981-14-000052

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →